ProFem GmbH

Back to list

Facts

Founded: 2012
Staff: 2
Organization type: RDM biotech/pharma
Region: Vienna
Cluster: LISAvienna
Focus: human health

Profile

Based on a highly innovative therapeutic concept ProFem develops new medicines for gynecological diseases which are characterized by a hitherto unmet medical need and high market potential. ProFem’s activities are currently focused on infectious diseases of the female lower genitourinary tract associated with the growth of biofilms.

R&D:About 150 million women worldwide are suffering constantly from recurrent vulvovaginal Candidosis (RVVC). This medical condition deteriorates the quality of life of infected women substantially, often for years, and currently cannot be treated successfully.

Similar companies in RDM biotech/pharma

Pharmazeutische Fabrik Montavit GmbH

Organization type: RDM biotech/pharma
Region: Tyrol
Cluster: Life Sciences Tyrol
Focus: human health

Details

YASARA Biosciences GmbH

Organization type: RDM biotech/pharma
Region: Vienna
Cluster: LISAvienna
Focus: bioinformatics

Details

Marinomed Biotech AG

Organization type: RDM biotech/pharma
Region: Vienna
Cluster: LISAvienna
Focus: human health
Topic: Covid-19 devices
anaesthetic and respiratory devices
opthalmic and optical devices
Focus R&D: applied research

Details

Ursapharm Ges.m.b.H.

Organization type: RDM biotech/pharma
Region: Lower Austria
Focus: human health

Details

Contact

Riglergasse 4
1180 Wien
Vienna

Contact: Marion Noe-Letsching (PhD, MD, CEO)
Email: marion.noe@profem.at
Website